Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
Selas T. F. Bots, Rob C. Hoeben
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4821-4821
Open Access | Times Cited: 23

Showing 23 citing articles:

Viral vector platforms within the gene therapy landscape
Jote Bulcha, Yi Wang, Hong Ma, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 964
Advances in Development and Application of Influenza Vaccines
Jidang Chen, Jiehuang Wang, Jipei Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 75
Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines
Prasad D. Trivedi, Barry J. Byrne, Manuela Corti
Viruses (2023) Vol. 15, Iss. 12, pp. 2378-2378
Open Access | Times Cited: 24
Adenovirus – a blueprint for gene delivery
Urs F. Greber, Alfonso Gómez-González
Current Opinion in Virology (2021) Vol. 48, pp. 49-56
Open Access | Times Cited: 39
Adenovirus entry: Stability, uncoating, and nuclear import
Urs F. Greber, Maarit Suomalainen
Molecular Microbiology (2022) Vol. 118, Iss. 4, pp. 309-320
Open Access | Times Cited: 27
Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines
Sonia Marquez-Martinez, Aneesh Vijayan, Selina Khan, et al.
Current Opinion in Immunology (2023) Vol. 80, pp. 102282-102282
Open Access | Times Cited: 16
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
Lobke C.M. Hensen, Rob C. Hoeben, Selas T. F. Bots
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6828-6828
Open Access | Times Cited: 35
Exploring the potential of foodborne transmission of respiratory viruses
Bridget C. O’Brien, Lawrence Goodridge, Jennifer Ronholm, et al.
Food Microbiology (2020) Vol. 95, pp. 103709-103709
Open Access | Times Cited: 30
Research advances in replication-deficient viral vector vaccines
Junna Wang, Jin Cui, Guoxin Li, et al.
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Organoids: new frontiers in tumor immune microenvironment research
Yujia Yang, Jinlei Cui, Ya‐Jie Kong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Current development in adenoviral vectors for cancer immunotherapy
Greyson Biegert, Amanda Rosewell Shaw, Masataka Suzuki
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 571-581
Open Access | Times Cited: 17
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
Judit Giménez-Roig, Estela Núñez-Manchón, Ramón Alemany, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 16
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
Nayara Gusmão Tessarollo, Ana Carolina M. Domingues, Fernanda Antunes, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1863-1863
Open Access | Times Cited: 12
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates
Selas T. F. Bots, Vera Kemp, Steve J. Cramer, et al.
Human Gene Therapy (2021) Vol. 33, Iss. 5-6, pp. 275-289
Open Access | Times Cited: 11
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Arezki Chekaoui, Mariangela Garofalo, Beata Gad, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’ for the treatment of pancreatic ductal adenocarcinoma
Selas T. F. Bots, Tom J. Harryvan, Christianne Groeneveldt, et al.
Molecular Oncology (2023) Vol. 18, Iss. 5, pp. 1245-1258
Open Access | Times Cited: 3
Detection and Molecular Characterization of Adenoviruses in Captive and Free-Roaming African Green Monkeys (Chlorocebus sabaeus): Evidence for Possible Recombination and Cross-Species Transmission
Diana M. Mancuso, Kerry Gainor, Kerry M. Dore, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1605-1605
Open Access | Times Cited: 2
Preliminary concerns with vaccine vectors
Nevio Cimolai
Mutagenesis (2020) Vol. 35, Iss. 4, pp. 359-360
Open Access | Times Cited: 4
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus ‘GoraVir’ in Cultured Pancreatic Cancer Cells
Selas T. F. Bots, Sanne L. Landman, Martijn J. W. E. Rabelink, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 283-283
Open Access | Times Cited: 1
Adenoviruses
Qiwei Zhang
Elsevier eBooks (2024), pp. 2413-2428
Closed Access
Advanced Therapy Medicinal Products: Clinical, Non-clinical, and Quality Considerations
Enrico Mastrobattista, Erik Doevendans, Niek P. van Til, et al.
Pharmaceutical biotechnology (2024), pp. 323-399
Closed Access
Inhibition of B cell receptor signaling induced by the human adenovirus species D E3/49K protein
Andreas Hildenbrand, Precious Cramer, Milena Bertolotti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C
Selas T. F. Bots, Vera Kemp, Iris J. C. Dautzenberg, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9832-9832
Open Access | Times Cited: 2
Page 1

Scroll to top